Viewing Study NCT05786092


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2026-01-02 @ 12:34 PM
Study NCT ID: NCT05786092
Status: UNKNOWN
Last Update Posted: 2023-03-27
First Post: 2023-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Telemonitoring on Metabolic Variables in Severe Obesity
Sponsor: Istituto Auxologico Italiano
Organization:

Study Overview

Official Title: The Role of Home Telemonitoring in the Evaluation of Patients With Severe Obesity After a Period of Residential Metabolic Rehabilitation.
Status: UNKNOWN
Status Verified Date: 2023-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: teleob
Brief Summary: The goal of this clinical trial is to compare, in a population of severely obese patients, two different kinds of follow-up after discharge from in-hospital rehabilitation programme.

The main questions addressed are:

* primary outcome: comparing the dropout rate at month 11 of patients followed-up by a telemedicine methodology with that of a traditional outpatient visit follow-up.
* secondary outcome: comparing the amount of weight loss at month 11 in patients followed-up by telemedicine with that registered in patients followed-up by traditional outpatient visits.

Participants are given a set of instruments (scale, activity tracker, automatic blood pressure monitor, oxymeter, and glucometer) and asked to measure vital parameters following a predetermined schedule for one year. Subjects are asked to engage in regular physical activity and follow the nutritional guidelines received at the moment of discharge from hospital.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: